After ROC analysis of circPTPN22 expression in GC patients, gastritis patients, and healthy controls, it was found that its AUC was higher than that of traditional tumor markers CEA and CA199, and the AUC reached 0.892 after combined use. This evidence concerns the gene CEACAM5 and neoplasm.